BRBR vs REGN · P/E 27, rev $2.32B vs P/E 14, rev $14.34B
Bellring Brands LLC (BRBR) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Bellring Brands LLC (BRBR) is a packaged foods company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported BRBR revenue for 2025-09-30 was $2.32B. Net income was $216.2M. Revenue was up 16.1% from 2024-09-30 to 2025-09-30. BRBR currently screens at market cap $7.30B and trailing P/E 26.7.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
BRBR currently screens at market cap $7.30B and trailing P/E 26.7. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the BRBR and REGN stock pages for the full models.
Not investment advice.